600587 新華醫療
按盤價 
19.100 +1.570 (+8.956%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.532 | 10.291 | 9.705 | 11.969 | 5.470 |
| 總資產報酬率 ROA (%) | 3.110 | 4.581 | 4.070 | 4.804 | 2.022 |
| 投入資產回報率 ROIC (%) | 4.281 | 6.418 | 5.634 | 6.560 | 2.937 | 邊際利潤分析 |
| 銷售毛利率 (%) | 26.654 | 27.373 | 26.439 | 24.251 | 23.277 |
| 營業利潤率 (%) | 10.904 | 7.561 | 6.312 | 7.595 | 3.987 |
| 息稅前利潤/營業總收入 (%) | 11.087 | 7.521 | 6.601 | 8.244 | 5.104 |
| 淨利潤/營業總收入 (%) | 9.603 | 6.757 | 5.677 | 5.864 | 2.616 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.387 | 104.644 | 104.088 | 76.226 | 128.815 |
| 價值變動淨收益/利潤總額(%) | 6.911 | 12.680 | 1.106 | 24.143 | 14.804 |
| 營業外收支淨額/利潤總額(%) | 0.345 | -2.488 | -1.691 | -0.300 | -5.653 | 償債能力分析 |
| 流動比率 (X) | 1.294 | 1.258 | 1.069 | 1.026 | 0.961 |
| 速動比率 (X) | 0.804 | 0.785 | 0.631 | 0.643 | 0.575 |
| 資產負債率 (%) | 49.056 | 50.483 | 55.349 | 54.637 | 57.953 |
| 帶息債務/全部投入資本 (%) | 32.771 | 32.376 | 39.797 | 39.145 | -- |
| 股東權益/帶息債務 (%) | 199.483 | 202.896 | 146.619 | 147.483 | 113.833 |
| 股東權益/負債合計 (%) | 98.405 | 92.988 | 75.148 | 77.452 | 65.482 |
| 利息保障倍數 (X) | 76.019 | 52.278 | 16.728 | 12.281 | 3.836 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.232 | 61.084 | 63.546 | 62.257 | 0.000 |
| 存貨周轉天數 (天) | 168.485 | 162.998 | 140.631 | 116.483 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
